The blister cavities protect the product from moisture, oxygen and light. The pack is both senior-friendly and child-resistant, achieving an F=1 rating, as required for the U.S. The package design aims to give patients a sense of accomplishment as they progress through the therapy and ensure the prevention of CMV. Removing a tablet from the wallet provides visible evidence medication was taken that day. Each blister cavity is individualized with the corresponding day of the week, permitting patients to start treatment any given day and indicating when they will finish the pack. One tablet must be taken daily, with each wallet pack providing one week of therapy. It focusses on developing therapies to combat gastrointestinal. The package insert is contained within the 5/6 th panel. Synergy Pharmaceuticals (NASDAQ: SGYP) has filed for Chapter 11 bankruptcy in a voluntary petition with another pharmaceutical company absorbing most of the company’s assets once the move goes. Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. Branding and product description can be seen on the outer packaging. The wallet provides ample space for medication information and dosing instructions in a clear format to help patients. Published 1:30am EST Sydney, Aus, (ACN Newswire) - There is an immediate need for alternative treatments to combat the spread of Herpes type 1 & 2 strains. The opening instructions are clearly illustrated with prominent text and differentiating colors. Synergy Pharmacy employs the most advanced technology designed specifically for todays long-term care industry. Synergy Pharmaceuticals is a naturopathic-driven company that focuses on eradicating the incurable herpes virus for good. The post Synergy Pharmaceuticals Bankruptcy: SGYP Stock Plummets on Filing appeared first on InvestorPlace.This custom design again uses the Dosepak platform technology, integrating visual cues such as arrows to help guide each patient through daily dosing, encouraging compliance while keeping the dosing regimen simple to understand. More From InvestorPlaceġ0 Defensive Stocks to Protect Your Portfolio in 2019ġ0 Stocks to Buy With The Trade War on Pauseġ0 Goldman Sachs Top Stock Picks for 2019ġ0 Stocks to Buy for a Rate Hike Slowdown On the other hand, BHC stock is surging close to 6.9% on the move. SGYP stock is plummeting about 57.4% on Wednesday following the news, with shares now selling at 14 cents apiece. The Bausch Health acquisition of Synergy assets is expected to be completed with cash in hand. Trulance is also known as plecanatide and it may be a good strategical fit with Xifaxan (rifaximin), which is an antibiotic used to treat diarrhea and irritable bowel syndrome with diarrhea. Synergy Pharmaceuticals - Manufacturer of MAXIFEN-AQ Injections 1Ml, Caltrol Soft Gel Capsule, Caltrol Soft Gels, Most Economical Soft Gels Of Calcitriol. The company develops, produces and distributes naturopathic. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Synergy Pharmaceuticals is an Australian vitamin and health supplement company founded in 2007. (SGYP) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News SGYP Synergy Pharmaceuticals, Inc. The company has pioneered discovery, research and development efforts around analogs of uroguanylin, a naturally occurring human GI peptide, for the treatment of GI diseases and disorders. Bausch will add the product to its Salix business, according to a statement from CEO Joseph Papa. About Synergy Pharmaceuticals Synergy is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies. Synergy focuses in gastrointestinal therapies, which include its flagship Trulance product, which is a tablet that is taken once a day for adults who have chronic constipation and irritable bowel syndrome with constipation.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |